Akebia Therapeutics, Inc. (AKBA)
0.9189
+0.04
(+4.59%)
USD |
NASDAQ |
Aug 31, 16:00
0.9189
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Cash and Short Term Investments (Quarterly) : 157.26M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 157.26M |
| March 31, 2026 | 164.35M |
| December 31, 2025 | 186.54M |
| September 30, 2025 | 168.14M |
| June 30, 2025 | 137.31M |
| March 31, 2025 | 113.37M |
| December 31, 2024 | 51.87M |
| September 30, 2024 | 34.02M |
| June 30, 2024 | 39.50M |
| March 31, 2024 | 41.96M |
| December 31, 2023 | 42.92M |
| September 30, 2023 | 46.53M |
| June 30, 2023 | 53.57M |
| March 31, 2023 | 56.95M |
| December 31, 2022 | 90.47M |
| September 30, 2022 | 144.76M |
| June 30, 2022 | 143.89M |
| March 31, 2022 | 174.56M |
| December 31, 2021 | 149.80M |
| September 30, 2021 | 207.20M |
| June 30, 2021 | 246.99M |
| March 31, 2021 | 272.76M |
| December 31, 2020 | 269.08M |
| September 30, 2020 | 269.65M |
| June 30, 2020 | 295.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 115.77M |
| December 31, 2019 | 147.96M |
| September 30, 2019 | 145.88M |
| June 30, 2019 | 137.13M |
| March 31, 2019 | 168.04M |
| December 31, 2018 | 321.64M |
| September 30, 2018 | 390.14M |
| June 30, 2018 | 402.12M |
| March 31, 2018 | 393.03M |
| December 31, 2017 | 317.79M |
| September 30, 2017 | 329.70M |
| June 30, 2017 | 321.22M |
| March 31, 2017 | 251.80M |
| December 31, 2016 | 260.34M |
| September 30, 2016 | 161.32M |
| June 30, 2016 | 188.65M |
| March 31, 2016 | 217.02M |
| December 31, 2015 | 138.45M |
| September 30, 2015 | 157.47M |
| June 30, 2015 | 152.79M |
| March 31, 2015 | 100.33M |
| December 31, 2014 | 108.92M |
| September 30, 2014 | 118.34M |
| June 30, 2014 | 124.25M |
| March 31, 2014 | 132.15M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 140.90M |
| Exelixis, Inc. | 839.38M |
| ADMA Biologics, Inc. | 136.02M |
| Arcutis Biotherapeutics, Inc. | 238.86M |
| Relay Therapeutics, Inc. | 910.93M |